European Medicines Agency To Grant Fee Waivers To Applications For Bluetongue Vaccines
Apr 2nd 2008Drug InformationImmune System / Vaccines
The European Medicines Agency has decided to grant fee reductions to all applications for inactivated vaccines against Bluetongue, on the basis of the current epidemiological situation in relation to Bluetongue, the lack of authorised vaccines in the market and the potential impact to animal health.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
